Park KW - Search Results

1

A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.

Park KW, Kang SH, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Hur SH, Ryu JK, Lee BR, Park YW, Chae IH, Kim HS; HOST–ASSURE Investigators. Park KW, et al. Among authors: park yw, park th, park be. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2805-16. doi: 10.1016/j.jacc.2014.04.013. Epub 2014 May 7. J Am Coll Cardiol. 2014. PMID: 24814486 Free article. Clinical Trial.

2

The incidence and predictors of contrast-induced nephropathy in adequately hydrated elderly patients with impaired renal function.

Park KW, Koo BK, Kim HL, Kim YS, Jo SH, Lee HY, Kang HJ, Cho YS, Chung WY, Yeon TJ, Chae IH, Choi DJ, Kim HS, Oh BH, Park YB. Park KW, et al. Among authors: park yb. Nephrol Dial Transplant. 2007 Jun;22(6):1794-5. doi: 10.1093/ndt/gfm074. Epub 2007 Feb 26. Nephrol Dial Transplant. 2007. PMID: 17324945 No abstract available.

3

A prominent coronary Thebesian system.

Park KW, Kim YJ, Kim HS. Park KW, et al. Eur Heart J. 2007 Oct;28(20):2448. doi: 10.1093/eurheartj/ehm190. Epub 2007 Jun 3. Eur Heart J. 2007. PMID: 17548340 No abstract available.

4

Two cases of mediastinal hematoma after cardiac catheterization: A rare but real complication of the transradial approach.

Park KW, Chung JW, Chang SA, Kim KI, Chung WY, Chae IH. Park KW, et al. Int J Cardiol. 2008 Nov 28;130(3):e89-92. doi: 10.1016/j.ijcard.2007.05.093. Epub 2007 Jul 27. Int J Cardiol. 2008. PMID: 17673316

5

Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes.

Park KW, Hwang KK, Cho HJ, Hur J, Yang HM, Yoon CH, Kang HJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: park yb. Clin Chim Acta. 2008 Feb;388(1-2):156-66. doi: 10.1016/j.cca.2007.10.027. Epub 2007 Nov 4. Clin Chim Acta. 2008. PMID: 18037374

6

One year clinical and six month angiographic results of drug eluting stents for ST elevation acute myocardial infarction: 'real world' comparison between sirolimus- and paclitaxel-eluting stents.

Park KW, Cho YS, Chung JW, Yeon TJ, Chae IH, Choi DJ, Oh BH, Park YB, Chung WY. Park KW, et al. Among authors: park yb. Int J Cardiol. 2009 Jan 24;131(3):350-5. doi: 10.1016/j.ijcard.2007.10.025. Epub 2008 Jan 3. Int J Cardiol. 2009. PMID: 18180056

7

The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation.

Kim YS, Koo BK, Seo JB, Park KW, Suh JW, Lee HY, Park JS, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Kim HS, Oh BH, Park YB. Kim YS, et al. Among authors: park kw, park js, park yb. Catheter Cardiovasc Interv. 2009 Jul 1;74(1):58-63. doi: 10.1002/ccd.21961. Catheter Cardiovasc Interv. 2009. PMID: 19360868

8

Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial.

Park KW, Yoon JH, Kim JS, Hahn JY, Cho YS, Chae IH, Gwon HC, Ahn T, Oh BH, Park JE, Shim WH, Shin EK, Jang YS, Kim HS. Park KW, et al. Among authors: park je. Am Heart J. 2009 May;157(5):811-817.e1. doi: 10.1016/j.ahj.2009.02.008. Am Heart J. 2009. PMID: 19376305 Clinical Trial.

9

Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).

Kang SH, Park KH, Choi DJ, Park KW, Chung WY, Lim C, Kim KB, Kim HS. Kang SH, et al. Among authors: park kh, park kw. Am J Cardiol. 2010 Feb 1;105(3):343-51. doi: 10.1016/j.amjcard.2009.09.036. Am J Cardiol. 2010. PMID: 20102946

10

Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents.

Choi DH, Park KW, Yang HM, Lee HY, Park JS, Kang HJ, Kim YJ, Koo BK, Oh BH, Park YB, Kim HS. Choi DH, et al. Among authors: park kw, park js, park yb. Int J Cardiol. 2011 Jun 2;149(2):174-181. doi: 10.1016/j.ijcard.2010.01.001. Epub 2010 Feb 5. Int J Cardiol. 2011. PMID: 20138378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,303 results

Search Page

Filters